# Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

Study · id `cardio:ct-nct01850615` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01850615](<https://clinicaltrials.gov/study/NCT01850615>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01850615

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 323 participants.

## Technical summary

Registry record NCT01850615. Randomized; no masking; primary purpose treatment. Start 2013-09-23 (actual); primary completion 2014-11-17 (actual). Results posted on 2018-01-17.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 323 participants (enrolled count; ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Started: 2013-09-23 (actual) (ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Primary completion: 2014-11-17 (actual) (ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Completion: 2014-11-17 (actual) (ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Results first posted: 2018-01-17 (ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Countries: United States; Argentina; India; Mexico; Romania; Slovenia (ClinicalTrials.gov record NCT01850615, source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01850615-2019-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
- Acronym: onset® 3
- Condition: Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Faster-acting insulin aspart
- Intervention (Drug): basal insulin
- Lead sponsor: Novo Nordisk A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Novo Nordisk (`cardio:novo-nordisk`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3) (`cardio:pubmed-28345792`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1f74faa0008f19637683aea58a7f2317f704b8b115d1fb6e2f1b6daa2fc33930
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
